Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 365

1.

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

Chia SKL, Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Kim SB, Jakobsen EH, Harvey V, Robert N, Smith J 2nd, Harker G, Zhang B, Eli LD, Ye Y, Lalani AS, Buyse M, Chan A.

Breast Cancer Res. 2019 Mar 11;21(1):39. doi: 10.1186/s13058-019-1115-2.

2.

National Trends of Thoracic Endovascular Aortic Repair (TEVAR) Versus Open Thoracic Aortic Repair (OTAR) in Pediatric Blunt Thoracic Aortic Injury.

Hasjim BJ, Grigorian A, Barrios C Jr, Schubl S, Nahmias J, Gabriel V, Spencer D, Donayre C.

Ann Vasc Surg. 2019 Feb 22. pii: S0890-5096(19)30172-4. doi: 10.1016/j.avsg.2018.12.094. [Epub ahead of print]

PMID:
30802562
3.

Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab.

Barrios CH, Reinert T, Werutsky G.

Ecancermedicalscience. 2019 Jan 22;13:898. doi: 10.3332/ecancer.2019.898. eCollection 2019. Review.

4.

Locally advanced breast cancer in Brazil: current status and future perspectives.

Werutsky G, Nunes P, Barrios C.

Ecancermedicalscience. 2019 Jan 22;13:895. doi: 10.3332/ecancer.2019.895. eCollection 2019. Review.

5.

Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study.

Simon SD, Bines J, Werutsky G, Nunes JS, Pacheco FC, Segalla JG, Gomes AJS, Adam Van Eyll BMHR, Gimenes DL, Crocamo S, Freitas-Junior R, Lago LD, Queiroz GS, Jobim de Azevedo S, Rosa DD, Delgado G, Borges GS, Verônica do Nascimento Y, Zaffaroni F, Martínez-Mesa J, Barrios CHE.

Breast. 2019 Apr;44:113-119. doi: 10.1016/j.breast.2019.01.008. Epub 2019 Feb 2.

6.

Localization of Muscle Edema and Changes on Muscle Contractility After Dry Needling of Latent Trigger Points in the Gastrocnemius Muscle.

Baraja-Vegas L, Martín-Rodríguez S, Piqueras-Sanchiz F, Faundez-Aguilera J, Bautista IJ, Barrios C, Fernández-de-Las-Peñas C.

Pain Med. 2019 Feb 1. doi: 10.1093/pm/pny306. [Epub ahead of print]

PMID:
30715456
7.

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1.

Montemurro F, Ellis P, Anton A, Wuerstlein R, Delaloge S, Bonneterre J, Quenel-Tueux N, Linn SC, Irahara N, Donica M, Lindegger N, Barrios CH.

Eur J Cancer. 2019 Mar;109:92-102. doi: 10.1016/j.ejca.2018.12.022. Epub 2019 Jan 29.

8.

Effects of Neratinib on Health-Related Quality-of-Life in Women with HER2-Positive Early-Stage Breast Cancer: Longitudinal Analyses from the Randomized Phase III ExteNET Trial.

Delaloge S, Cella D, Ye Y, Buyse M, Chan A, Barrios CH, Holmes FA, Mansi J, Iwata H, Ejlertsen B, Moy B, Chia SKL, Gnant M, Smichkoska S, Ciceniene A, Martinez N, Filipovic S, Ben-Baruch NE, Joy AA, Langkjer ST, Senecal F, de Boer RH, Moran S, Yao B, Bryce R, Auerbach A, Fallowfield L, Martin M.

Ann Oncol. 2019 Jan 23. doi: 10.1093/annonc/mdz016. [Epub ahead of print]

PMID:
30689703
9.

Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.

de la Rubia JE, Drehmer E, Platero JL, Benlloch M, Caplliure-Llopis J, Villaron-Casales C, de Bernardo N, AlarcÓn J, Fuente C, Carrera S, Sancho D, GarcÍa-Pardo P, Pascual R, JuÁrez M, Cuerda-Ballester M, Forner A, Sancho-Castillo S, Barrios C, Obrador E, Marchio P, Salvador R, Holmes HE, Dellinger RW, Guarente L, Estrela JM.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jan 22:1-8. doi: 10.1080/21678421.2018.1536152. [Epub ahead of print]

PMID:
30668199
10.

Bone quality in young adults with intellectual disability involved in adapted competitive football.

Lizondo V, Caplliure-Llopis J, Escrivá D, De La Rubia JE, Barrios C.

Eur J Sport Sci. 2019 Jan 9:1-10. doi: 10.1080/17461391.2018.1563633. [Epub ahead of print]

PMID:
30624162
11.

PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114).

Werutsky G, Hochhegger B, Lopes de Figueiredo Pinto JA, Martínez-Mesa J, Zanini ML, Berdichevski EH, Vilas E, da Silva VD, Tsukazan MTR, Vieira A, Fritscher LG, Hartmann L, Alba M, Sartori G, Matushita C, Bortolotto V, do Amaral RR, Junior LCA, Zaffaroni F, Barrios CH, Debiasi M, Frietscher CC.

BMC Cancer. 2019 Jan 3;19(1):5. doi: 10.1186/s12885-018-5233-5.

12.

Pressure Ulcer in Trauma Patients: A Higher Spinal Cord Injury Level Leads to Higher Risk.

Grigorian A, Sugimoto M, Joe V, Schubl S, Lekawa M, Dolich M, Kuncir E, Barrios C Jr, Nahmias J.

J Am Coll Clin Wound Spec. 2018 Jun 19;9(1-3):24-31.e1. doi: 10.1016/j.jccw.2018.06.001. eCollection 2017.

13.
14.

Comparison of Comorbid Conditions Between Cancer Survivors and Age-Matched Patients Without Cancer.

Roy S, Vallepu S, Barrios C, Hunter K.

J Clin Med Res. 2018 Dec;10(12):911-919. doi: 10.14740/jocmr3617w. Epub 2018 Oct 30.

15.

Membrane Attack Complex and Factor H in Humans with Acute Kidney Injury.

Rodríguez E, Gimeno J, Arias-Cabrales C, Barrios C, Redondo-Pachón D, Soler MJ, Crespo M, Sierra-Ochoa A, Riera M, Pascual J.

Kidney Blood Press Res. 2018;43(5):1655-1665. doi: 10.1159/000494680. Epub 2018 Oct 31.

16.

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Hegg R, Im SA, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA; IMpassion130 Trial Investigators.

N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20.

PMID:
30345906
17.

Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations.

Barrios C, Zierer J, Würtz P, Haller T, Metspalu A, Gieger C, Thorand B, Meisinger C, Waldenberger M, Raitakari O, Lehtimäki T, Otero S, Rodríguez E, Pedro-Botet J, Kähönen M, Ala-Korpela M, Kastenmüller G, Spector TD, Pascual J, Menni C.

Sci Rep. 2018 Oct 15;8(1):15249. doi: 10.1038/s41598-018-33507-7.

18.

Relevant advances in bone lengthening research: a bibliometric analysis of the 100 most-cited articles published from 2001 to 2017.

Mohedano A, Castillo A, de Pablos J, Barrios C.

J Pediatr Orthop B. 2018 Oct 11. doi: 10.1097/BPB.0000000000000557. [Epub ahead of print]

PMID:
30312248
19.

Analysis of the conflicts of interest disclosed by the program reviewers of the scoliosis research society (SRS) congresses, 2010-2014.

Barrios C, Alfonso J, Lloris JM, Hevia E, Burgos J.

PLoS One. 2018 Oct 11;13(10):e0204993. doi: 10.1371/journal.pone.0204993. eCollection 2018.

20.

Design of an Aluminum/Polymer Plasmonic 2D Crystal for Label-Free Optical Biosensing.

Tramarin L, Barrios CA.

Sensors (Basel). 2018 Oct 5;18(10). pii: E3335. doi: 10.3390/s18103335.

21.

Stage III Non-Small-Cell Lung Cancer Treated With Concurrent Chemoradiation Followed or Not by Consolidation Chemotherapy: A Survival Analysis From a Brazilian Multicentric Cohort.

Cordeiro de Lima VC, Baldotto CS, Barrios CH, Sobrinho EM, Zukin M, Mathias C, Zaffaroni F, Nery RC, Madeira G, Amadio AV, Coelho JC, Geib G, Simões MF, Castro G Jr.

J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00214.

22.

Global Breast Cancer Research: Moving Forward.

Barrios CH, Reinert T, Werutsky G.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):441-450. doi: 10.1200/EDBK_209183. Review.

PMID:
30231347
23.

A Propensity Score Analysis of Clostridium difficile Infection among Adult Trauma Patients.

Gabriel V, Grigorian A, Phillips JL, Schubl SD, Barrios C, Pejcinovska M, Won E, Nahmias J.

Surg Infect (Larchmt). 2018 Oct;19(7):661-666. doi: 10.1089/sur.2018.110. Epub 2018 Sep 11.

PMID:
30204556
24.

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study.

Lee DH, Tsao MS, Kambartel KO, Isobe H, Huang MS, Barrios CH, Khattak A, de Marinis F, Kothari S, Arunachalam A, Cao X, Burke T, Valladares A, de Castro J.

PLoS One. 2018 Aug 27;13(8):e0202865. doi: 10.1371/journal.pone.0202865. eCollection 2018.

25.

National analysis of testicular and scrotal trauma in the USA.

Grigorian A, Livingston JK, Schubl SD, Hasjim BJ, Mayers D, Kuncir E, Barrios C, Joe V, Nahmias J.

Res Rep Urol. 2018 Aug 10;10:51-56. doi: 10.2147/RRU.S172848. eCollection 2018. Review.

26.

National risk factors for blunt cardiac injury: Hemopneumothorax is the strongest predictor.

Grigorian A, Milliken J, Livingston JK, Spencer D, Gabriel V, Schubl SD, Kong A, Barrios C, Joe V, Nahmias J.

Am J Surg. 2019 Apr;217(4):639-642. doi: 10.1016/j.amjsurg.2018.07.043. Epub 2018 Jul 25.

PMID:
30060913
27.

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.

Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios CH, Bergh J, Biganzoli L, Boers-Doets CB, Cardoso MJ, Carey LA, Cortés J, Curigliano G, Diéras V, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Gelmon K, Johnston SRD, Kaufman B, Koppikar S, Krop IE, Mayer M, Nakigudde G, Offersen BV, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo HS, Sledge GW, Spence D, Thomssen C, Vorobiof DA, Xu B, Norton L, Winer EP.

Ann Oncol. 2018 Aug 1;29(8):1634-1657. doi: 10.1093/annonc/mdy192. No abstract available.

PMID:
30032243
28.

Severe hyperkyphosis reduces the aerobic capacity and maximal exercise tolerance in patients with Scheuermann disease.

Lorente A, Barrios C, Lorente R, Tamariz R, Burgos J.

Spine J. 2019 Feb;19(2):330-338. doi: 10.1016/j.spinee.2018.07.002. Epub 2018 Jul 17.

PMID:
30025996
29.

Association of Heparin-Induced Thrombocytopenia With Bacterial Infection in Trauma Patients.

Grigorian A, Schubl S, Barrios C Jr, Joe V, Dolich M, Lekawa M, Nahmias J.

JAMA Surg. 2018 Oct 1;153(10):964-965. doi: 10.1001/jamasurg.2018.1652. No abstract available.

PMID:
29955756
30.

Predominance of Studies With Poor Level of Evidence Among the Top 100 Most Cited Studies on Idiopathic Scoliosis: A Bibliometric and Content Analysis.

Gambín-Botella J, Ayala M, Alfonso-Beltrán J, Barrios C.

Spine Deform. 2018 Jul - Aug;6(4):373-383. doi: 10.1016/j.jspd.2017.12.003. Review.

PMID:
29886907
31.

National Trends of Thoracic Endovascular Aortic Repair Versus Open Repair in Blunt Thoracic Aortic Injury.

Grigorian A, Spencer D, Donayre C, Nahmias J, Schubl S, Gabriel V, Barrios C Jr.

Ann Vasc Surg. 2018 Oct;52:72-78. doi: 10.1016/j.avsg.2018.03.045. Epub 2018 Jun 7.

PMID:
29886219
32.

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

Lambertini M, Campbell C, Bines J, Korde LA, Izquierdo M, Fumagalli D, Del Mastro L, Ignatiadis M, Pritchard K, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Barrios CH, Baselga J, Moreno-Aspitia A, Piccart M, Gelber RD, de Azambuja E.

J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094.

PMID:
29878225
33.

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.

Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O.

Front Oncol. 2018 May 22;8:156. doi: 10.3389/fonc.2018.00156. eCollection 2018. Review.

34.

Pure Retroperitoneal Optical Access Trocar for Lumbar Diseases in Adults: A Step-by-Step Technique.

Nunes-Silva I, Hidaka A, Barrios C, Azevedo E, Ferreira Faria E, Zampoli H, Bertrand G, Tobias-Machado M.

Surg Laparosc Endosc Percutan Tech. 2018 Jun;28(3):159-163. doi: 10.1097/SLE.0000000000000533.

PMID:
29738379
35.

Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.

Montero N, Favà A, Rodriguez E, Barrios C, Cruzado JM, Pascual J, Soler MJ.

Cochrane Database Syst Rev. 2018 May 7;5:CD011403. doi: 10.1002/14651858.CD011403.pub2. Review.

PMID:
29734473
36.

Total vertebrectomy and spine shortening for the treatment of T12-L1 spine dislocation: Management with suboptimal resources.

Lorente A, Palacios P, Burgos J, Barrios C, Lorente R.

Neurocirugia (Astur). 2018 Nov - Dec;29(6):304-308. doi: 10.1016/j.neucir.2018.03.001. Epub 2018 Apr 22. English, Spanish.

PMID:
29691146
37.

The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments.

Raez LE, Cardona AF, Santos ES, Catoe H, Rolfo C, Lopes G, Barrios C, Mas LA, Vallejos C, Zatarain-Barrón ZL, Caglevic C, Arrieta O.

Lung Cancer. 2018 May;119:7-13. doi: 10.1016/j.lungcan.2018.02.014. Epub 2018 Mar 2. Review.

PMID:
29656755
38.

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.

Wu YL, Sequist LV, Tan EH, Geater SL, Orlov S, Zhang L, Lee KH, Tsai CM, Kato T, Barrios CH, Schuler M, Hirsh V, Yamamoto N, O'Byrne K, Boyer M, Mok T, Peil B, Märten A, Chih-Hsin Yang J, Paz-Ares L, Park K.

Clin Lung Cancer. 2018 Jul;19(4):e465-e479. doi: 10.1016/j.cllc.2018.03.009. Epub 2018 Mar 17.

39.

eFAST for Pneumothorax: Real-Life Application in an Urban Level 1 Center by Trauma Team Members.

Maximus S, Figueroa C, Whealon M, Pham J, Kuncir E, Barrios C.

Am Surg. 2018 Feb 1;84(2):220-224.

PMID:
29580349
40.

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B; CheckMate 214 Investigators.

N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21.

41.

Lung cancer in Brazil.

Araujo LH, Baldotto C, Castro G Jr, Katz A, Ferreira CG, Mathias C, Mascarenhas E, Lopes GL, Carvalho H, Tabacof J, Martínez-Mesa J, Viana LS, Cruz MS, Zukin M, Marchi P, Terra RM, Ribeiro RA, Lima VCC, Werutsky G, Barrios CH; Grupo Brasileiro de Oncologia Torácica.

J Bras Pneumol. 2018 Jan-Feb;44(1):55-64. doi: 10.1590/S1806-37562017000000135. Review. English, Portuguese.

42.

Outcomes of early parent-child adrenocortical attunement in the high-risk offspring of depressed parents.

Merwin SM, Barrios C, Smith VC, Lemay EP Jr, Dougherty LR.

Dev Psychobiol. 2018 May;60(4):468-482. doi: 10.1002/dev.21623. Epub 2018 Mar 12.

PMID:
29528109
43.

Risk of hysterectomy and salpingectomy or oophorectomy compared to repair after pelvic gynecologic trauma.

Grigorian A, Joe V, Delaplain PT, Schubl S, Barker B, Gabriel V, Dosch AR, Barrios C Jr, Nahmias J.

Eur J Trauma Emerg Surg. 2018 Mar 6. doi: 10.1007/s00068-018-0936-5. [Epub ahead of print]

PMID:
29511771
44.

Clinical and radiological outcomes after stand-alone ALIF for single L5-S1 degenerative discopathy using a PEEK cage filled with hydroxyapatite nanoparticles without bone graft.

Norotte G, Barrios C.

Clin Neurol Neurosurg. 2018 May;168:24-29. doi: 10.1016/j.clineuro.2018.01.037. Epub 2018 Jan 31.

PMID:
29505978
45.

Impact of Recurrent Acute Kidney Injury on Patient Outcomes.

Rodríguez E, Arias-Cabrales C, Bermejo S, Sierra A, Burballa C, Soler MJ, Barrios C, Pascual J.

Kidney Blood Press Res. 2018;43(1):34-44. doi: 10.1159/000486744. Epub 2018 Jan 23.

46.

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.

Knox JJ, Barrios CH, Kim TM, Cosgriff T, Srimuninnimit V, Pittman K, Sabbatini R, Rha SY, Flaig TW, Page RD, Beck JT, Cheung F, Yadav S, Patel P, Geoffrois L, Niolat J, Berkowitz N, Marker M, Chen D, Motzer RJ.

Ann Oncol. 2018 Nov 1;29(11):2269. doi: 10.1093/annonc/mdx807. No abstract available.

47.

Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review.

Reinert T, Barrios CH.

Ther Adv Med Oncol. 2017 Nov;9(11):693-709. doi: 10.1177/1758834017728928. Epub 2017 Sep 8. Review.

48.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Beşe N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW.

Cancer Discov. 2018 Mar;8(3):336-353. doi: 10.1158/2159-8290.CD-17-0535. Epub 2017 Dec 14.

49.

Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer.

Reinert T, Debiasi M, Bines J, Barrios CH.

Breast Cancer Res Treat. 2018 Apr;168(2):457-465. doi: 10.1007/s10549-017-4593-x. Epub 2017 Nov 30. Review.

PMID:
29190006
50.

Is Autologous Blood Transfusion cost effective in Adolescent Idiopathic Scoliosis?

Sanpera I, Burgos-Flores J, Barrios C, Piza-Vallespir G, Anton-Rodrigalvarez LM.

Acta Orthop Belg. 2016 Dec;82(4):901-906.

PMID:
29182137

Supplemental Content

Loading ...
Support Center